Report for Adams R

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Translating clinical notes into quantitative measures-a real-world observation on the response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records - Chotiyanonta_2023_Front.Pharmacol_14_1177026
Author(s) : Chotiyanonta JS , Onda K , Nowrangi MA , Li X , Xu X , Adams R , Lyketsos CG , Zandi P , Oishi K
Ref : Front Pharmacol , 14 :1177026 , 2023
Abstract : Chotiyanonta_2023_Front.Pharmacol_14_1177026
ESTHER : Chotiyanonta_2023_Front.Pharmacol_14_1177026
PubMedSearch : Chotiyanonta_2023_Front.Pharmacol_14_1177026
PubMedID: 37234714

Title : Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques - Rosenberg_2013_Chem.Biol.Interact_203_167
Author(s) : Rosenberg YJ , Laube B , Mao L , Jiang X , Hernandez-Abanto S , Lee KD , Adams R
Ref : Chemico-Biological Interactions , 203 :167 , 2013
Abstract : Rosenberg_2013_Chem.Biol.Interact_203_167
ESTHER : Rosenberg_2013_Chem.Biol.Interact_203_167
PubMedSearch : Rosenberg_2013_Chem.Biol.Interact_203_167
PubMedID: 23178380

Title : Cholinesterase inhibitors and Alzheimer's disease outcomes -
Author(s) : Garcia A , Thompson K , Zanibbi K , Geick S , Adams R
Ref : J Gerontol A Biol Sci Med Sci , 62 :570 , 2007
PubMedID: 17522364